Products
B2B Zone
4th Rare and Genetic Kidney Disease Drug Development Summit
4th Rare and Genetic Kidney Disease Drug Development Summit
Conferences

4th Rare and Genetic Kidney Disease Drug Development Summit

By

Hanson Wade

2 Followers
10 Dec 2024 - 12 Dec 2024
Free Registration

Event Details

4th Rare and Genetic Kidney Disease Drug Development Summit

With recent accelerated approval wins, positive clinical trial readouts, progression through clinical pipelines and exciting mergers and acquisitions, it has certainly been an industry-defining year for the rare and genetic renal space.

In the context of rapid progress and a mounting desire to propel game-changing novel therapies that will add to the arsenal of therapeutic options for patients, the 4th Rare and Genetic Kidney Disease Drug Development Summit returns to Boston. This unique event for the industry, academic KOL, and patient advocacy nephrology community provides an unrivalled opportunity to discuss acceleration of clinical advancements in orphan kidney disease populations.

This year's meeting brings together 30+ expert speakers, a two-tracked pre-conference workshop day and new content on podocyte biology, tissue bioengineering of kidney tissue models, market access strategies, as well as pricing and reimbursement conversations, across a breadth of rare renal therapeutic areas including FSGS, PKD, Alport Syndrome and IgAN to name but a few!

URLs:
Website: https://go.evvnt.com/2595572-0?pid=10018
Tickets: https://go.evvnt.com/2595572-2?pid=10018
Brochure: https://go.evvnt.com/2595572-3?pid=10018

Prices:
Conference + Discover and Translational Workshops - Industry: USD 4197.00,
Conference + Clinical and Market Access Workshops - Industry: USD 4197.00,
Conference Only - Industry: USD 2999.00,
Conference + Discover and Translational Workshops - Academic: USD 3597.00,
Conference + Clinical and Market Access Workshops - Academic: USD 3597.00,
Conference Only - Academic: USD 2599.00,
Conference + Discover and Translational Workshops - Vendor: USD 5097.00,
Conference + Clinical and Market Access Workshops - Vendor: USD 5097.00,
Conference Only - Vendor: USD 3699.00

Speakers: Robbie McCarthy, USA General Manager, Advicenne S.A., B. Andre Weinstock, Research Director, Alport Syndrome Foundation, Stephen Olson, Senior Medical Director, Early Clinical Development, AstraZeneca, Weining Lu, Associate Professor, Boston University, Laurence H. Beck Jr., Nephrologist and David J. Salant MD Professor of Nephrology, Boston University, Richard Watt, Associate Professor and Chief Scientific Officer, Brigham Young University and REVITALE Pharma, Achim Obergfell, Global Medical Head Nephrology, CSL Vifor, Doug Paul, VP Commercial Strategy and Founder, Cypress BioPharma, Sumit Aggarwal, President and Chief Executive Officer, Eloxx Pharmaceuticals, Balaji Karthick Subramanian, Assistant Professor of Medicine, Harvard Medical School, Dongwon Lee, Assistant Professor of Pediatrics, Harvard Medical School, Friedhelm Hildebrandt, Professor of Pediatrics, Nephrology, Harvard Medical School, Dario Lemos, Assistant Professor of Medicine, Harvard Medical School and Brigham and Women's Hospital, Laurel Damashek, Executive Director, International Society of Glomerular Disease, Neel Anand, Senior Vice President, Research and Drug Discovery, Kezar Life Sciences, Susan Limb, Vice President, Clinical Science, Maze Therapeutics, Adele Rowley, Chief Scientific Officer, Mironid Ltd., David Feldman, Senior Medical Project Director, National Kidney Foundation, William Smoyer, VP, Nationwide Children's Hospital, Joshua Tarnoff, Chief Executive Officer, NephCure Kidney International, Jee Yeon Kim, Associate Clinical Research Medical Director (Renal), Novartis AG, Srini Srinivas, Senior Medical Director, Renal Diseases and Evidence Generation Lead, Novartis AG, Gerard Honig Associate Director, Biomarker Research, Otsuka Pharmaceutical Development and Commercialization, Inc, Michelle M. Richardson Director, Patient-Centered Research and Clinical Outcome Assessments, Otsuka Pharmaceuticals Development and Commercialization, Inc, Pille Harrison, VP Clinical Development, Purespring Therapeutics, John Seman, Chief Executive Officer, REVITALE Pharma, Chris Smith, President and Chief Executive Officer, SmithSolve LLC, Rachel McComb, Senior Clinical Operations Progam, Lead Rare GI2, Takeda Pharmaceutical, Kevin Fowler, Principal, The Voice of the Patient, Sean Eddy, Associate Research Scientist, NEPTUNE Match Molecular Profiling Lead, University of Michigan, Eloise Salmon, Clinical Assistant Professor, University of Michigan, Kerry Cooper, Senior Vice President Medical Affairs, Vera Therapeutics, Alex Duncan, Chief Scientific Officer, Walden Biosciences, Allen Davidoff, Chief Executive Officer, XORTX Therapeutics Inc.

Entry Fees

Free Registration

Categories

Event Frequency

One Time

Event Timings

(GMT-5:00) Central Time (US and Canada)
08:00 AM - 05:30 PM (Dec 10, Dec 11, Dec 12) (General)

Speakers

Robbie McCarthy
Robbie McCarthy
USA General Manager, Advicenne S.A.
B. Andre Weinstock
B. Andre Weinstock
Research Director, Alport Syndrome Foundation
Stephen Olson
Stephen Olson
Senior Medical Director, Early Clinical Development, AstraZeneca

Comments on 4th Rare and Genetic Kidney Disease Drug Development Summit

You must to write a comment.

Peoples Interested in Visit

0 Peoples Interested to Visit

Event Location

Revere Hotel
200, Stuart Street, Bay Village, Boston ,
Boston 02116, Massachusetts, United States
Official Link :

More Events By Organizer

2nd Covalent Drug Discovery and Development Summit
2nd Covalent Drug Discovery and Development Summit
10
Dec
2024
Free
Conferences
Personalized Cancer Vaccine Summit
Personalized Cancer Vaccine Summit
03
Dec
2024
Free
Conferences
Cell and Gene Therapy Medical Affairs Summit
Cell and Gene Therapy Medical Affairs Summit
03
Dec
2024
Free
Conferences
Patient Recruitment for Rare Disease Trials Summit 2024
Patient Recruitment for Rare Disease Trials Summit 2024
10
Dec
2024
Free
Conferences
GPCRs-Targeted Drug Discovery Summit Europe
GPCRs-Targeted Drug Discovery Summit Europe
26
Nov
2024

GPCRs-Targeted Drug Discovery Summit Europe

Greater London, United Kingdom
Free
Conferences
Portfolio Strategy and Decision Making for Biopharma Summit 2024
Portfolio Strategy and Decision Making for Biopharma Summit 2024
21
Nov
2024

Similar Events

Investment in Pakistan & Central Asia Conference
Investment in Pakistan & Central Asia Conference
21
Dec
2022
Check Official Website
Conferences
Solar PV World Expo (PV Guangzhou)
Solar PV World Expo (PV Guangzhou)
08
Aug
2023
Free
Exhibitions
Bangor University Application and On-Spot Offer Day
Bangor University Application and On-Spot Offer Day
02
Nov
2023
TowerXchange Meetup Africa 2024
TowerXchange Meetup Africa 2024
10
Sep
2024
Free
Conferences
Benefits of Signin
  • Publish Your Event for Free
  • Find Upcoming Events Near By
  • Grow Your B2B Network
  • Fix B2B Meeting Online/Event
  • Showcase Products to Right People